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Abstract. – OBJECTIVE: The main goal of 
oncoplastic breast surgery (OBS) is to optimize 
cosmetic outcomes and reduce patient morbid-
ity, while still providing an oncologically-safe 
surgical outcome and extending the target pop-
ulation of conservative surgery. Although the 
growing number of reported experiences with 
oncoplastic surgery, few studies account for the 
long-term outcomes. 
PATIENTS AND METHODS: Between Janu-
ary 2000 and December 2010, 1024 consecutive 
oncoplastic surgeries were performed and pro-
spectively included in a database. Demograph-
ic data, histological and oncological evaluation 
and surgical complications were recorded. The 
role of tumor and patients’ characteristics on 
the development of local recurrence and metas-
tases were assessed by multivariate analysis.
RESULTS: Median follow up was 74.2 months. 
The average age of patients was 56.24. In 869 
patients (84.9%) an invasive tumor and in 155 
(15.1%) an in situ tumor (11% DCIS and 4% LIN) 
was found. The average size of the tumor was 
24.5 mm. A positive margin was presented in 67 
(6.5%) patients. Forty patients (50%) underwent 
re-excision and 39 (49.4%) underwent mastec-
tomy. The overall breast conservation rate was 
96.2%. Reported complications were: 17 wound 
infections (1.7%); 106 hematomas (10.4%); 94 
lymphorrheas (9.2%), 48 partial wound dehis-
cence (4.7%). Local recurrences (LR) were ob-
served in 49 patients (4.7%). The risk of local re-
currence was significantly higher in the group of 
patients with lymphovascular invasion and with 
high grade (G) (p < 0.05). 52 (5.07%) distant me-
tastases were reported and the related risk was 
significantly higher in the group of patients with 
lymphovascular invasion and with negative re-
ceptors (p < 0.05).
CONCLUSIONS: Oncoplastic surgery pro-
vides an acceptable oncological long-term outcome 
and can be used to treat with conservative surgery 
also a selected population of patients who would 
had otherwise undergone mastectomy in the past.
Key Words:
Breast cancer (BC), Breast conservative surgery 
(BCS), Oncoplastic surgery, Oncoplasty, Breast con-
serving surgery, Local recurrence, Therapeutic mam-
moplasty.
Introduction
Immediate breast reconstruction, following 
breast conservative surgery (BCS), has repre-
sented a significant innovation in breast cancer 
treatment (BCT), founding the basis of oncoplas-
tic approach. 
The success of BCS for early-stage breast can-
cer is based on a merge of complete excision of the 
tumor with adequate oncologically-safe margins 
with the attempt to preserve the natural shape and 
appearance of the breast. Indeed clinical trials 
have demonstrated similar oncological outcomes 
and long-term survival in patients with breast 
cancer who underwent mastectomy or breast-con-
serving surgery1,2. These findings extended the 
indication for breast-conserving therapy up to 80% 
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of patients with breast cancer, owing also to recent 
improvements in screening modalities and neoad-
juvant chemotherapy regimens3.
Despite of reliable rate of recurrences and 
the purported safe oncological outcome of con-
servative surgeries, it has been reported that an 
approximate 25% of these patients experienced 
an unsatisfactory cosmetic results3,4.
Oncoplastic breast surgery (OBS), following 
conventional mammaplasty techniques, was de-
veloped with the aim of optimizing cosmetic 
outcomes, reducing patient morbidity, while still 
providing an oncologically-safe surgical proce-
dure and extending the target population of con-
servative surgery. 
Over the last twenty years, the development of 
this new surgical approach has been extremely 
fast, due to the increasing attention related to 
the quality of life of patients5-7. Indeed, different 
studies have shown that cosmetic results, follow-
ing breast surgery, can play a great influence on 
the final psychological outcome8-10. 
Oncoplastic techniques vary from the simple 
mobilization of a dermo-glandular flap to correct 
the defect of limited exeresis to the use of local 
or distant pedicle flaps to completely replace 
mammary volume, following mastectomy8-10. Al-
though OBS presents a number of advantages 
over BCS, there are still some concerns regard-
ing this approach, mainly owing to the lack 
of evidence on long-term safety, aesthetic and 
health-related quality of life outcomes.
The aim of this study is to evaluate the onco-
logical outcome in a single-institution series of 
1024 patients, who underwent breast conservative 
surgery, followed by an oncoplastic procedure. 
The study followed the ethical standards of hu-
man experimentation, according to the Declara-
tion of Helsinki.
Patients and Methods
This study is a prospective evaluation of a 
single institution series of patient undergoing 
oncoplastic BCS. 
Between January 2000 and December 2010, 
1024 consecutive patients diagnosed with invasive 
or in situ breast cancer undergoing oncoplastic re-
constructive surgery at our institution were includ-
ed in the study. Patients with previous ipsilateral or 
contralateral breast cancer were excluded.
All enrolled patients underwent a full pre-
operative workup, including appropriate imag-
ing, biopsy, and image-guided marker placement. 
Magnetic resonance (MRI) was used only when 
multicentricity was suspected or in case of dense 
breast. 
Data were prospectively recorded in a database 
with SQTM® (“Scheda computerizzata per il con-
trollo della Qualità del Trattamento del carcinoma 
Mammario software”) software (CPO, Tourin, Ita-
ly). The following characteristics were prospectively 
recorded in the dataset: demographic data, age, 
BMI, tumour size, histological evaluation, surgical 
and oncological management, surgical complica-
tions, time and site of recurrence, adjuvant or neo-
adjuvant radiotherapy and chemotherapy data.
All the therapeutic options were discussed and 
decided by a multidisciplinary team, including a 
breast surgeon, a plastic surgeon, a pathologist, 
a radiologist, an oncologist, a radiotherapist and 
a psyco-oncologist. Oncoplastic technique was 
determined by patients’ anatomy, preferences and 
tumor location. All patients were treated with 
an oncoplastic approach, when a significant vol-
ume excision was followed by reshaping of the 
breast parenchyma with volume displacement 
technique, accompanied by an adequate skin en-
velope reduction9. 
Prior to anesthesia induction, all patients were 
preoperatively marked sitting and in the upright 
position and both breasts were draped into the 
operative field for comparison. The patient was 
centered on the operating table fitting both the su-
pine and upright position, in order to better eval-
uate intraoperatively an optimal reshaping and 
symmetry of the breast. The patient was placed 
with either arms extended in case of axillary sur-
gery or with both arms at the sides if no axillary 
surgery was scheduled. In all cases, following 
skin excision oncoplastic techniques considered 
a full-thickness excisions of the tumor from the 
subcutaneous fat underlying the skin up to the 
pectoralis fascia. Patients had intraoperative lo-
calization with palpation and, in case of non-pal-
pable lesions, an intraoperative radiographical 
evaluation was performed. 
Metal clips were placed on the pectoralis muscle 
and lateral edges of the resection bed before clos-
ing the defect in order to guide future radiotherapy. 
All patient were informed about possible post-
operative breast asymmetry, as a consequence 
of extensive resection that may result in volume 
asymmetry, if compared with the contralateral 
breast. According to patients’ preferences, con-
tralateral symmetrization was performed during 
the same operation. 
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The surgical treatment of the axilla was carried 
out by biopsy of the sentinel lymph nodes (BSL) 
or axillary dissection.
Margins were considered positive when tu-
mor involved the margin of resection and clear 
if the closest margin to the excision plane was at 
least 2 mm. In the case of positive or not clear 
margins a re-excision was performed. Radio-
therapy, chemotherapy and hormone therapy 
were administered according to oncological in-
dications.
During the first five years, patients were fol-
lowed up every 6 months by clinical examination 
and every 12 months by surveillance mammo-
gram. Abnormal clinical findings were further 
investigated as appropriate. Since the 5th year 
follow up was carried out yearly.
Recurrences were documented by clinical ex-
amination, radiological tests and/or pathological 
assessment. Local and distant recurrence rates 
were the primary outcomes and were evaluated 
as the oncological safety outcome. Senior author 
(DR) revised data and outcomes.
Statistical Analysis
Multivariate COX proportional regression was 
used to assess the independent prognostic value 
of selected tumor and patients’ characteristics on 
the development of local recurrence and metasta-
ses. Statistical analysis was performed with SPSS 
Statistics (SPSS Inc., Chicago, IL, USA). All tests 
were two-sided. p-values were considered statisti-
cally significant if p < 0.005.
Results
During the study period 1024 patients underwent 
oncoplastic reconstructive surgery for breast cancer. 
Tumor and patient characteristics are shown in Ta-
ble I and Figure 1 account for histopathology. 
The average age of patients was 56.24 (range 
25-85, standard deviation ± 11.44). Pre-meno-
pausal patients were 363 (35.4%). 
In 511 patients (49.9%) the tumor was in the 
right breast. In 513 patients (50.1%) it was in the 
left breast. In 869 patients (84.9%) an invasive tu-
mor and in 155 (15.1%) an in situ tumor (11% was 
DCIS and 4% was LIN) was found. The average 
size of the tumor determined by histopathology 
was 24.5 mm (range 10-60). Surgical techniques 
features are reported in Table II.
All patients underwent oncoplastic surgery. 
360 patients (35.4%) were submitted, during the 
the same procedure, to a contralateral symme-
trization in order to avoid asymmetry following 
oncological surgery, with the discovering of some 
undiagnosed lesions in the contralateral paren-
chyma (Table III). 
Table I. Characteristics of woman who underwent oncoplas-
tic surgery.
 Cases
 (No. = 1024) %
Age (years)
  < 35 16 1.6%
  35-44 137 13.4%
  45-54 355 34.7%
  55-64 249 24.3%
  65-74 201 19.6%
  ≥ 75 66 6.4%
Tumor size (mm)
  11-20 467 45.6%
  21-30 428 41.8%
  > 30 129 12.6%
Grading
  I 254 24.8%
  II 430 42%
  III 251 24.5%
Unknown 89 8.7%
Vascular invasion
  Yes 234 22.8%
  No 790 77.2%
Multifocal tumors
  Yes 211 20.6%
  No 813 79.4%
Surgical margins
  Negative 909 88.8%
  Positive 67 6.5%
  Close 48 4.7%
pN
  Nx 7 0.7%
  N0 616 60%
  N1mi 7 0.7%
  N1a 323 31.7%
  N2a 61 6%
  N3a 10 0.9%
Ki 67
  ≤ 16 531 44%
  > 16 482 39.8%
  Unknow 11 16.2%
Adjuvant chemotherapy 387 37
Neo adjuvant chemotherapy 41 4%
No chemotherapy 596 58.2%
Adjuvant hormonotherapy
  Yes 826 80.7%
  No 198 19.3%
Boost radiotherapy
  Yes 456 44.5%
  No 568 55.5%
Hormone receptor status
  ER and PgR positive 831 81.2%
  ER and PgR negative 97 9.5%
  ER and PgR not applicable 96 9.3%
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Complete excision of the tumor was obtained 
in 909 cases (88.8%). In 115 cases margins re-
sulted to be positive or close (11.2%). A positive 
margin was present in 67 (6.5%) patients. In 79 
patients (7.7%) a second operation was carried 
out at an average time of 38.5 days from the 
first one (range 26-45). Forty patients (50%) 
underwent re-excision and 39 (49.4%) under-
went mastectomy. Mastectomy was performed 
in case of multifocal tumor, lobular invasive 
cancer, linfovascular invasion or when a second 
conservative operation would have determined 
an unsatisfactory cosmetic outcome. Ten (25%) of 
the 40 patients who underwent a new conserva-
tive treatment presented a multifocal cancer, but 
no positive margins were detected at the time of 
second surgery. 
Sentinel lymph node biopsy was carried out in 845 
patients (82.5%). Complete axillary dissection was 
carried out in 421 patients (41.1%), 264 out of 421 as a 
consequence of positive sentinel lymph node. 
Reported complications were: 17 wound in-
fections (1.7%); 106 hematomas (10.4%); 94 lym-
phorrheas (9.2%), 48 partial wound dehiscences 
(4.7%) (Table IV). In 11 cases (1.07%) the compli-
cations delayed the adjuvant treatment.
Local Recurrence and Metastases
Median follow up was 74.2 months, 11 patients 
were lost at follow-up (1.07%).
Local recurrences (LR) were observed in 49 
patients (4.7%) in an average time of 34.2 months 
(range 16-59) (Table V).
The risk of local recurrence was significantly 
higher in the group of patients with lymphovascu-
lar invasion and with high grade (G) (Table VI).
52 patients (5.07%) developed distant metasta-
ses, in an average time of 34.7 months after the 
first surgery (range 18-67). The metastases were 
localized in: bone 19, liver 9, brain 5, lung 14, 
multiple organs 5 (Table VII). The risk of distant 
metastases was significantly higher in the group 
of patients with lymphovascular invasion and 
with negative receptors (Table VI).
Seventeen patients (1.6%) died for cancer relat-
ed death in an average time of 46.5 months after 
the first surgery (range 3-58) (Table VIII). Ten of 
them (58.8%) were T2 tumors, 7 patients (41.2%) 
were T1; 9 (52.9%) were G3, no patients were 
G1; 7 patients (41.2%) were ER/PgR negative and 
14 patients (82.4%) had positive axillary lymph 
nodes; 1 patient died 3 months after surgery from 
a myocardial ischemia. No events were recorded 
in the group with DCIS.
Discussion
BCS supplemented with postoperative radio-
therapy has become the standard of treatment for 
the majority of patients with breast cancer, with 
Figure 1. Distribution of Histopathology.
Table II. Techniques.
 Technique N Percentage
Donut mastopexy 315 31%
Superior pedicle Wise Pattern 135 13%
Inferior pedicle Wise Pattern 196 19%
Grisotti  84  8%
Comma shape 114 11%
Medial pedicle mastopexy  90  9%
Lateral pedicle mastopexy  90  9%
Table III. Histological findings of contro-lateral breast.
  Cases
 Histopatological findings (n = 307)
Normal breast tissue 91 (29.6%)
Fibrocystic disease 73 (23.8%)
Proliferative disease with atypia 64 (20.8%)
Ductal carcinoma in situ (DCIS) 29 (9.5%)
Lobular carcinoma in situ (LCIS) 42 (13.7%)
Invasive ductal carcinoma 8 (2.6%)
Table IV. Complications.
 N Percentage 
Wound infection  17 1.7%
Lymphorrhea  94 9.2%
Partial wound 
dehiscence  48 4.7%
Hematomas 106 10.4%
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reported survival rate similar to that of radical 
surgery and improved body image and health 
related quality of life scores9. 
BCS has not always produced good cosmetic 
results in all patients, promoting the growth and 
advancement of new techniques in breast sur-
gery9. Oncoplasty was developed with the goals 
of providing an oncologically safe long-term out-
come while fulfilling the request for an accept-
able aesthetic outcome.
Oncoplasty can be integrated in every type 
of BCS; breast volume and appearance along 
Table V. Characteristics of patients with local relapse.
      Vascular  Menopausal Margins Ki67
 Patients Age pT G N invasion ER/PgR state involved (%)
 1 40 2 2 1a + Pos Pre 0 70
 2 41 2 2 1 _ Neg Pre 0 80
 3 45 2 3 1 _ Neg Pre 0 90
 4 46 1C 2 0 + Pos Pre 0 70
 5 48 1C 3 1a + Pos Pre 0 80
 6 50 2 3 1c + Pos Pre 1 90
 7 50 2 2 1c + Na Post 0 90
 8 53 2 2 1a + Pos Post 0 80
 9 54 1c 3 1a + Pos Post 0 80
10 55 1C 2 1a _ Pos Post 0 80
11 44 2 2 1a _ Pos Pre 1 80
12 59 2 2 1a + Pos Post 0 80
13 63 1b 3 1c + Neg Post 0 85
14 41 2 2 1a + Pos Pre 0 80
15 42 2 3 1c + Pos Pre 0 85
16 44 2 3 1 _ Pos Pre 0 80
17 45 1c 3 0 + Pos Pre 0 75
18 48 1c 3 1 + Pos Pre 0 70
19 49 2 2 1a + Pos Pre 0 70
20 49 2 3 1 + Pos Pre 0 80
21 53 2 2 0 + Pos Post 0 90
22 57 1 3 0 _ Neg Post 0 70
23 63 2 2 0 _ Pos Post 0 90
24 46 2 2 2 + Pos Post 0 70
25 48 1b 3 1a + Pos Pre 0 80
26 50 1c 3 2 + Pos Pre 0 75
27 50 1c 2 2a + Pos Pre 0 15
28 53 1a 3 1c + Neg Post 0 60
29 55 2 3 0 _ Pos Post 0 60
30 58 2 2 1c _ Pos Pre 0 70
31 39 1c 3 1a _ Pos Pre 0 80
32 41 1c 2 1a + Pos Pre 0 70
33 42 1c 3 2 + Pos Pre 0 60
34 43 1b 3 0 + Pos Pre 0 60
35 47 1c 2 2 + Pos Pre 0 60
36 49 1c 3 0 _ Neg Pre 0 70
37 53 1c 2 1a + Pos Post 0 40
38 53 1c 2 1a + Pos Post 0 50
39 53 2 2 1 + Pos Pre 0 55
40 63 1c 3 1a + Pos Post 0 70
41 63 1c 2 2 + Pos Post 0 80
42 81 1a 2 0 + Pos Post 0 60
43 78 2 2 0 _ Neg Post 0 60
44 77 2 2 1 + Pos Post 0 70
45 62 1c 2 1c _ Pos Post 0 60
46 58 1c 2 1c + Pos Post 0 70
47 66 1a 2 0 + Pos Post 0 60
48 55 1c 3 1c + Pos Pre 0 70
49 49 1b 3 0 + Pos 1 0 60
*Vascular invasion: + = Presence; – = absence **Margin involved = 0 = No; 1 = Yes.
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with tumors’ ratio and localization are the main 
factors that account for the choice of the proper 
oncoplastic technique8-14. As reported by differ-
ent studies the relation between tumor size and 
breast volume has been looked as the fundamen-
tal item in determining the cosmetic result9,15. 
The percentage of breast volume excised has been 
associated with cosmesis and patient satisfaction 
outcomes9. 
Moreover, the oncoplastic reconstructive sur-
geon has to bear in mind the tumor location. 
Usatisfactory cosmetic results have been reported 
as a frequent occurence following the excision of 
tumor of the upper internal quadrant and inferior 
quadrants9. 
Although a growing body of reported expe-
riences with oncoplastic surgery, few studies in 
literature account for the long-term outcomes of 
this technique. In this study we report a single 
centre ten years’ experience about 1024 patients 
undergoing conservative surgery with an on-
coplastic approach. The mean follow up was 
74.2 months and the local recurrences rate was 
evaluated as low as 4.7%. These data fit in with 
the results already reported in literature16-24. The 
NSABP BO6 trial, the Milano 1 Trial and the In-
stitute Curie of Paris study reported a prevalence 
of local recurrence (LR) of respectively 4%, 5.3% 
and 9.4% after five years20-22. In another study by 
De Lorenzi et al23 the 5-year local recurrence rate 
was 3.2%23. In a series of 540 oncoplastic patients 
the local recurrence rate was assessed as 6.8% 
with a median follow up of 49 months25. Recently 
Clough et al26 released a long-term follow-up 
study on a series of 350 oncoplastic reduction 
with a 2.2% 5-year LR rate.
In our study, a positive margin was present in 
67 (6.5%) patients. This rate was lower than those 
reported by other studies16-31. In 79 patients (7.7%) 
a second operation was carried out: forty patients 
(50%) successfully underwent re-excision and 39 
(49.4%) underwent mastectomy. Thus the overall 
breast conservation rate was 96.2%.
The conservative approach associated to on-
coplastic techniques allowed us to obtain free 
resection margin in 89% of patients. This result 
suggests that oncoplastic surgery could be con-
sidered a safe approach, with decreased likeli-
Table VI. Rates of local recurrences and metastases according to different parameters.
                        Local recurrence                                  Metastases 
 Characteristics No. of patients p No. of patients p
Overall 49  52 
Menopausal status  0.870  0.730
  Pre 27  25 
  Post 23  27 
Diameter of primary tumour  0.953  0.536
  1-20 mm 10  30
  > 21 mm 39  22 
Grading  0.001  0.128
  G1  0   1 
  G2 27  30 
  G3 22  21 
Axillary nodes  0.547  0.166
  Involved 37  40
  Not involved 12  12 
Vascular invasion  0.000  0.001
  Yes 36  29 
  No 13  23 
Margins  0.423  0.939
  Yes  2   0 
  No 47   0 
ER/PgR  0.375  0.000
  + 41  35 
  –  8  17 
*Local recurrence: p-value is statistically significant in G and vascular invasion (df = 1; CI 95%). Metastasis: p-value is 
statistically significant in vascular invasion and receptors (df = 1; CI 95%)
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hood of surgical revision (7.7% in our series). 
Considering complications, hematoma was the 
most frequently observed, with 42 patients who 
underwent surgical revision. Only in 11 patients 
(1%) complications resulted in delayed adjuvant 
therapies.
Table VII. Characteristics of patients with metastasis.
     Vascular  Chemio Chemio Hormono Menopausal Ki67
Patients Age pT G pN invasion ER/PgR pre post therapy state (%)
 1 41 2 2 1 _ Neg N N 0 Pre 80
 2 45 2 3 1 _ Neg N N 0 Pre 90
 3 49 1c 2 2 + Neg N Y 2 Post 60
 4 50 2 2 1 _ Neg N N 0 Pre 60
 5 52 2 1 0 _ Neg N N 0 Pre 70
 6 55 1C 2 1a _ Pos N Y 2 Post 80
 7 44 2 2 1a _ Pos N Y 1 Pre 80
 8 49 4 3 3a + Pos Y Y 1 Pre 60
 9 49 1c 2 0 + Neg N Y 0 Pre 70
10 50 1c 3 0 _ Pos Y N 1 Pre 90
11 53 1c 2 0 _ Pos N N 1 Pre 60
12 58 1c 2 1a + Pos N Y 1 Post 70
13 59 2 2 1a + Pos N Y 1 Post 80
14 61 1b 2 1 + Pos N Y 2 Post 80
15 62 1c 3 1a + Neg N Y 0 Post 75
16 63 1b 3 1c + Neg N Y 0 Post 85
17 64 2 2 1 _ Pos N N 1 Post 75
18 39 2 2 1 + Pos N Y 1 Pre 70
19 39 1c 3 0 _ Pos N Y 1 Pre 80
20 42 2 3 1c + Pos N Y 1 Pre 85
21 43 1a 3 1c _ Neg Y N 0 Pre 80
22 48 1c 3 0 _ Neg N Y 0 Pre 70
23 49 4 3 1c _ Pos N Y 1 Pre 75
24 54 2 2 1c + Pos N Y 2 Post 85
25 58 2 2 2 + Pos N Y 2 Post 85
26 63 2 2 0 _ Pos N Y 1 Post 90
27 30 2 3 1c + Pos N Y 1 Pre 70
28 46 1a 2 0 _ Pos N N 1 Pre 80
29 50 1b 2 1 _ Pos Y N 2 Post 60
30 51 2 3 1a + Pos Y N 2 Post 60
31 51 1c 3 1c _ Pos N Y 1 Pre 90
32 54 2 3 2 + Pos N Y 1 Pre 85
33 58 1a 3 0 _ Neg N Y 0 Post 75
34 58 1b 2 1a + Pos N Y 2 Post 75
35 66 2 2 1c _ Pos N Y 2 Post 80
36 67 1c 3 0 _ Pos N N 1 Post 80
37 68 1c 2 1 _ Pos N Y 1 Post 75
38 40 2 2 1a + Neg N Y 0 Pre 60
39 47 1c 3 2 + Pos Y N 1 Pre 70
40 51 1c 2 1c + Pos N Y 2 Post 70
41 52 1c 3 1a + Neg N Y 0 Pre 60
42 53 1c 2 1a + Pos N N 2 Post 50
43 54 1b 3 0 + Neg N N 0 Pre 75
44 55 2 2 1 + Neg N Y 0 Pre 75
45 56 1a 2 1c + Pos N Y 2 Post 80
46 58 1c 2 1a + Neg N Y 0 Post 80
47 68 1a 2 0 _ Pos N N 2 Post 75
48 71 2 3 2 + Pos N N 2 Post 80
49 77 2 2 1 + Pos N N 2 Pre 70
50 62 1c 2 1c _ Pos N Y 2 Post 60
51 80 3 2 0 + Pos N N 2 Post 80
52 38 1b 3 2 + Neg N Y 0 Post 70
*Y= Yes; N = NO. **Hormonotherapy: 0 = Nothing; 1 = Tamoxifene; 2 = Aromatase inhibitor.
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Furthermore, when the oncological procedure 
would result in a serious deficiency of mammary 
tissue with consequent breast asymmetry, we 
planned a bilateral surgery16-22, adjusting the vol-
ume of the contralateral breast. A contralateral 
symmetrization was carried out during the same 
operation, according to previous studies27-29. In-
deed this technique, although increasing surgery 
time, leads to obtain excellent aesthetic results 
while reducing postural problems, back pain and 
dysfunction, strongly affecting routinely life of 
these patients30-53. 
Conclusions
In this study we reported our ten years case-
load with oncoplastic surgery, accounting for 
long term outcomes of this procedure. We found 
that oncoplastic surgery provides an acceptable 
oncological outcome, even if we believe that 
these results must be confirmed with a longer 
follow-up. The oncoplastic approach allowed 
for the treatment with conservative surgery 
also that a selected population of patients who 
would had otherwise undergone mastectomy in 
the past. 
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